176 related articles for article (PubMed ID: 20305142)
21. Understanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A erythroblasts.
Khandros E; Huang P; Peslak SA; Sharma M; Abdulmalik O; Giardine BM; Zhang Z; Keller CA; Hardison RC; Blobel GA
Blood; 2020 May; 135(22):1957-1968. PubMed ID: 32268371
[TBL] [Abstract][Full Text] [Related]
22. PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis.
Spinello I; Quaranta MT; Pasquini L; Pelosi E; Petrucci E; Pagliuca A; Castelli G; Mariani G; Diverio D; Foà R; Testa U; Labbaye C
Oncogene; 2009 Jun; 28(23):2276-88. PubMed ID: 19421145
[TBL] [Abstract][Full Text] [Related]
23. Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.
González I; Andreu EJ; Panizo A; Inogés S; Fontalba A; Fernández-Luna JL; Gaboli M; Sierrasesúmaga L; Martín-Algarra S; Pardo J; Prósper F; de Alava E
Clin Cancer Res; 2004 Jan; 10(2):751-61. PubMed ID: 14760098
[TBL] [Abstract][Full Text] [Related]
24. [Functional expression of Flt3 and c-kit on cord blood CD34(+) stem/progenitor cells and its significance].
Ma YP; Zou P; Xiao J; Huang SA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):277-80. PubMed ID: 12513756
[TBL] [Abstract][Full Text] [Related]
25. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.
Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A
Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte-macrophage colony-stimulating factor reactivates fetal hemoglobin synthesis in erythroblast clones from normal adults.
Gabbianelli M; Pelosi E; Bassano E; Labbaye C; Petti S; Rocca E; Tritarelli E; Miller BA; Valtieri M; Testa U
Blood; 1989 Dec; 74(8):2657-67. PubMed ID: 2479426
[TBL] [Abstract][Full Text] [Related]
27. Retroviral-mediated gene transduction of c-kit into single hematopoietic progenitor cells from cord blood enhances erythroid colony formation and decreases sensitivity to inhibition by tumor necrosis factor-alpha and transforming growth factor-beta1.
Lu L; Heinrich MC; Wang LS; Dai MS; Zigler AJ; Chai L; Broxmeyer HE
Blood; 1999 Oct; 94(7):2319-32. PubMed ID: 10498604
[TBL] [Abstract][Full Text] [Related]
28. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor.
Sakabe H; Kimura T; Zeng Z; Minamiguchi H; Tsuda S; Yokota S; Hodohara K; Abe T; Lyman SD; Sonoda Y
Eur J Haematol; 1998 May; 60(5):297-306. PubMed ID: 9654159
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of MicroRNA-221 and 222 Enhances Hematopoietic Differentiation from Human Pluripotent Stem Cells via c-KIT Upregulation.
Lee JY; Kim M; Heo HR; Ha KS; Han ET; Park WS; Yang SR; Hong SH
Mol Cells; 2018 Nov; 41(11):971-978. PubMed ID: 30396237
[TBL] [Abstract][Full Text] [Related]
30. Cellular regulation of hemoglobin switching: evidence for inverse relationship between fetal hemoglobin synthesis and degree of maturity of human erythroid cells.
Papayannopoulou T; Kalmantis T; Stamatoyannopoulos G
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6420-4. PubMed ID: 293729
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis.
Felli N; Pedini F; Romania P; Biffoni M; Morsilli O; Castelli G; Santoro S; Chicarella S; Sorrentino A; Peschle C; Marziali G
Haematologica; 2009 Apr; 94(4):479-86. PubMed ID: 19278969
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of imatinib on normal progenitor cells in vitro.
Bartolovic K; Balabanov S; Hartmann U; Komor M; Boehmler AM; Bühring HJ; Möhle R; Hoelzer D; Kanz L; Hofmann WK; Brümmendorf TH
Blood; 2004 Jan; 103(2):523-9. PubMed ID: 12969987
[TBL] [Abstract][Full Text] [Related]
33. microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome.
Akçakaya P; Caramuta S; Åhlen J; Ghaderi M; Berglund E; Östman A; Bränström R; Larsson C; Lui WO
Br J Cancer; 2014 Nov; 111(11):2091-102. PubMed ID: 25349971
[TBL] [Abstract][Full Text] [Related]
34. Umbilical vein endothelial cells are an important source of c-kit and stem cell factor which regulate the proliferation of haemopoietic progenitor cells.
Yamaguchi H; Ishii E; Saito S; Tashiro K; Fujita I; Yoshidomi S; Ohtubo M; Akazawa K; Miyazaki S
Br J Haematol; 1996 Sep; 94(4):606-11. PubMed ID: 8826881
[TBL] [Abstract][Full Text] [Related]
35. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.
Sankaran VG; Menne TF; Xu J; Akie TE; Lettre G; Van Handel B; Mikkola HK; Hirschhorn JN; Cantor AB; Orkin SH
Science; 2008 Dec; 322(5909):1839-42. PubMed ID: 19056937
[TBL] [Abstract][Full Text] [Related]
36. Lacking deoxygenation-linked interaction between cytoplasmic domain of band 3 and HbF from fetal red blood cells.
Weber RE
Acta Physiol (Oxf); 2007 Nov; 191(3):247-52. PubMed ID: 17935525
[TBL] [Abstract][Full Text] [Related]
37. Circulating cytokines response and the level of erythropoiesis in sickle cell anemia.
Croizat H; Nagel RL
Am J Hematol; 1999 Feb; 60(2):105-15. PubMed ID: 9929101
[TBL] [Abstract][Full Text] [Related]
38. Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210.
Sarakul O; Vattanaviboon P; Tanaka Y; Fucharoen S; Abe Y; Svasti S; Umemura T
Blood Cells Mol Dis; 2013 Aug; 51(2):98-103. PubMed ID: 23623309
[TBL] [Abstract][Full Text] [Related]
39. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression.
Shaw TJ; Keszthelyi EJ; Tonary AM; Cada M; Vanderhyden BC
Exp Cell Res; 2002 Feb; 273(1):95-106. PubMed ID: 11795950
[TBL] [Abstract][Full Text] [Related]
40. The Shift of HbF to HbA under Influence of SKA2 Gene; A Possible Link between Cortisol and Hematopoietic Maturation in Term and Preterm Newborns.
Ijabi J; Afrisham R; Moradi-Sardareh H; Roozehdar P; Seifi F; Sahebkar A; Ijabi R
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):485-494. PubMed ID: 32364083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
